Chuck Royce's INVA Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 1.17 M shares of Innoviva, Inc. (INVA) worth $26.63 M, representing 0.21% of the portfolio. First purchased in 2017-Q3, this long-term strategic position has been held for 36 quarters.
Based on 13F filings, Chuck Royce has maintained a strategic position in INVA, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 437,654 shares. Largest reduction occurred in Q4 2023, reducing 32,373 shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's Innoviva (INVA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Innoviva (INVA) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +111,242 | Add 10.48% | 1.17 M | $22.71 |
| Q1 2026 | +141,131 | Add 15.34% | 1.06 M | $23.30 |
| Q4 2025 | +414,411 | Add 81.91% | 920,317 | $19.99 |
| Q3 2025 | +437,654 | Add 641.23% | 505,906 | $18.25 |
| Q2 2025 | -1,872 | Reduce 2.67% | 68,252 | $20.09 |
| Q1 2025 | +10,499 | Add 17.61% | 70,124 | $18.13 |
| Q4 2024 | +1,717 | Add 2.97% | 59,625 | $17.35 |
| Q3 2024 | +13,414 | Add 30.15% | 57,908 | $19.31 |
| Q2 2024 | -24,612 | Reduce 35.61% | 44,494 | $16.40 |
| Q1 2024 | -15,071 | Reduce 17.90% | 69,106 | $15.24 |
| Q4 2023 | -32,373 | Reduce 27.78% | 84,177 | $16.04 |
| Q3 2023 | -1,814 | Reduce 1.53% | 116,550 | $12.99 |
| Q2 2023 | +944 | Add 0.80% | 118,364 | $12.73 |
| Q1 2023 | +18,054 | Add 18.17% | 117,420 | $11.25 |
| Q4 2022 | +18,155 | Add 22.36% | 99,366 | $13.25 |
| Q3 2022 | +2,914 | Add 3.72% | 81,211 | $11.61 |
| Q2 2022 | -2,192 | Reduce 2.72% | 78,297 | $14.76 |
| Q1 2022 | -10,472 | Reduce 11.51% | 80,489 | $19.34 |
| Q4 2021 | +4,600 | Add 5.33% | 90,961 | $17.25 |
| Q3 2021 | +1,081 | Add 1.27% | 86,361 | $16.71 |
| Q2 2021 | +2,837 | Add 3.44% | 85,280 | $13.41 |
| Q1 2021 | +3,728 | Add 4.74% | 82,443 | $11.95 |
| Q4 2020 | +2,091 | Add 2.73% | 78,715 | $12.39 |
| Q3 2020 | +736 | Add 0.97% | 76,624 | $10.45 |
| Q2 2020 | +206 | Add 0.27% | 75,888 | $13.98 |
| Q1 2020 | -267 | Reduce 0.35% | 75,682 | $11.76 |
| Q4 2019 | +15,064 | Add 24.74% | 75,949 | $14.15 |
| Q3 2019 | +26,193 | Add 75.50% | 60,885 | $10.54 |
| Q2 2019 | +14,944 | Add 75.67% | 34,692 | $14.56 |
| Q1 2019 | +18,449 | Add 1420.25% | 19,748 | $14.03 |
| Q4 2018 | -615 | Reduce 32.13% | 1,299 | $17.71 |
| Q3 2018 | +719 | Add 60.17% | 1,914 | $15.15 |
| Q2 2018 | +522 | Add 77.56% | 1,195 | $13.39 |
| Q1 2018 | -174 | Reduce 20.54% | 673 | $16.34 |
| Q4 2017 | +91 | Add 12.04% | 847 | $14.17 |
| Q3 2017 | +756 | New Buy | 756 | $14.55 |
Chuck Royce's Innoviva Investment FAQs
Chuck Royce first purchased Innoviva, Inc. (INVA) in Q3 2017, acquiring 756 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held Innoviva, Inc. (INVA) for 36 quarters since Q3 2017.
Chuck Royce's largest addition to Innoviva, Inc. (INVA) was in Q3 2025, adding 505,906 shares worth $9.23 M.
According to the latest 13F filing for Q2 2026, Chuck Royce's firm, Royce & Associates Lp, owns 1,172,690 shares of Innoviva, Inc. (INVA), valued at approximately $26.63 M.
As of the Q2 2026 filing, Innoviva, Inc. (INVA) represents approximately 0.21% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in Innoviva, Inc. (INVA) was 1,172,690 shares, as reported at the end of Q2 2026.